Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	55,419	50,360	34,746	32,794	-	-
Market Cap Growth	44.94%	44.94%	5.95%	-	-	-
Enterprise Value	49,183	43,851	31,750	31,531	-	-
Last Close Price	52.35	48.78	34.09	32.18	-	-
PE Ratio	23.88	22.95	21.73	41.68	-	-
Forward PE	19.42	19.66	19.71	-	-	-
PS Ratio	9.40	8.54	8.95	12.27	-	-
PB Ratio	7.31	6.65	7.22	10.23	-	-
P/TBV Ratio	7.33	6.66	7.24	10.26	-	-
P/FCF Ratio	29.02	26.37	22.19	37.24	-	-
P/OCF Ratio	25.51	23.18	19.14	31.14	-	-
PEG Ratio	0.96	0.85	-	-	-	-
EV/Sales Ratio	8.34	7.44	8.18	11.80	-	-
EV/EBITDA Ratio	19.86	17.72	17.54	24.07	-	-
EV/EBIT Ratio	20.29	18.06	17.88	24.61	-	-
EV/FCF Ratio	25.76	22.96	20.28	35.80	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	-	-
Debt / FCF Ratio	0.00	0.00	0.00	0.00	-	-
Asset Turnover	0.85	0.85	0.87	0.43	0.30	0.54
Inventory Turnover	3.88	3.88	3.00	2.70	2.57	3.18
Quick Ratio	7.21	7.21	7.36	8.16	1.07	1.02
Current Ratio	7.66	7.66	7.79	9.03	1.09	1.05
Return on Equity (ROE)	35.88%	35.88%	40.18%	51.98%	112.30%	102.70%
Return on Assets (ROA)	21.92%	21.92%	24.84%	12.86%	10.81%	22.61%
Return on Capital (ROIC)	24.80%	24.80%	27.93%	36.73%	77.18%	62.50%
Return on Capital Employed (ROCE)	31.70%	31.70%	36.30%	39.70%	88.00%	168.60%
Earnings Yield	3.96%	4.36%	4.60%	3.45%	-	-
FCF Yield	3.45%	3.79%	4.51%	2.69%	-	-
Dividend Yield	2.42%	1.31%	1.42%	-	-	-
Payout Ratio	44.05%	44.05%	-	36.67%	307.92%	-
Buyback Yield / Dilution	-1.93%	-1.93%	3.77%	-2.03%	-0.09%	-
Total Shareholder Return	0.61%	-0.62%	5.19%	-2.03%	-0.09%	-

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.